相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunotherapy Targeting Pathological Tau Protein in Alzheimer's Disease and Related Tauopathies
Einar M. Sigurdsson
JOURNAL OF ALZHEIMERS DISEASE (2017)
Lithium Treatment Arrests the Development of Neurofibrillary Tangles in Mutant Tau Transgenic Mice with Advanced Neurofibrillary Pathology
Karelle Leroy et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Hyperphosphorylated tau in young and middle-aged subjects
Adila Elobeid et al.
ACTA NEUROPATHOLOGICA (2012)
Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau
Ann Van der Jeugd et al.
ACTA NEUROPATHOLOGICA (2012)
Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies
David J. Irwin et al.
BRAIN (2012)
Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy
Veronique Schaeffer et al.
BRAIN (2012)
Targeting Phospho-Ser422 by Active Tau Immunotherapy in the THY-Tau22 Mouse Model: A Suitable Therapeutic Approach
Laetitia Troquier et al.
CURRENT ALZHEIMER RESEARCH (2012)
Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity
Chronis Fatouros et al.
HUMAN MOLECULAR GENETICS (2012)
Trans-cellular Propagation of Tau Aggregation by Fibrillar Species
Najla Kfoury et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Paired Helical Filaments from Alzheimer Disease Brain Induce Intracellular Accumulation of Tau Protein in Aggresomes
Ismael Santa-Maria et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
Peter T. Nelson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Selectively Silencing GSK-3 Isoforms Reduces Plaques and Tangles in Mouse Models of Alzheimer's Disease
David E. Hurtado et al.
JOURNAL OF NEUROSCIENCE (2012)
Hyperdynamic Microtubules, Cognitive Deficits, and Pathology Are Improved in Tau Transgenic Mice with Low Doses of the Microtubule-Stabilizing Agent BMS-241027
Donna M. Barten et al.
JOURNAL OF NEUROSCIENCE (2012)
The Microtubule-Stabilizing Agent, Epothilone D, Reduces Axonal Dysfunction, Neurotoxicity, Cognitive Deficits, and Alzheimer-Like Pathology in an Interventional Study with Aged Tau Transgenic Mice
Bin Zhang et al.
JOURNAL OF NEUROSCIENCE (2012)
Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation
Scott A. Yuzwa et al.
NATURE CHEMICAL BIOLOGY (2012)
Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export
Peng Lei et al.
NATURE MEDICINE (2012)
Fyn knock-down increases Aβ, decreases phospho-tau, and worsens spatial learning in 3 x Tg-AD mice
S. Sakura Minami et al.
NEUROBIOLOGY OF AGING (2012)
Diagnostic power of default mode network resting state fMRI in the detection of Alzheimer's disease
Walter Koch et al.
NEUROBIOLOGY OF AGING (2012)
Long-term oral lithium treatment attenuates motor disturbance in tauopathy model mice: Implications of autophagy promotion
Kohei Shimada et al.
NEUROBIOLOGY OF DISEASE (2012)
Propagation of Tau Pathology in a Model of Early Alzheimer's Disease
Alix de Calignon et al.
NEURON (2012)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Trans-Synaptic Spread of Tau Pathology In Vivo
Li Liu et al.
PLOS ONE (2012)
The pathological process underlying Alzheimer's disease in individuals under thirty
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2011)
Tau pathology in children and young adults: can you still be unconditionally baptist?
Charles Duyckaerts
ACTA NEUROPATHOLOGICA (2011)
Extended results of the Alzheimer's disease anti-inflammatory prevention trial
John C. Breitner et al.
ALZHEIMERS & DEMENTIA (2011)
Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial
Orestes V. Forlenza et al.
BRITISH JOURNAL OF PSYCHIATRY (2011)
Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's disease
Michael Voronkov et al.
FUTURE MEDICINAL CHEMISTRY (2011)
Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models REDUCTION OF TAU PATHOLOGY AND DELAY OF DISEASE PROGRESSION
Xiyun Chai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Seeding of Normal Tau by Pathological Tau Conformers Drives Pathogenesis of Alzheimer-like Tangles
Jing L. Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Are Tangles as Toxic as They Look?
Tara L. Spires-Jones et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2011)
A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S)-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease
Tomohiro Onishi et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain
Allal Boutajangout et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Immunoelectron Microscopic and Biochemical Studies of Caspase-Cleaved Tau in a Mouse Model of Tauopathy
Wen-Lang Lin et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Tau-Induced Defects in Synaptic Plasticity, Learning, and Memory Are Reversible in Transgenic Mice after Switching Off the Toxic Tau Mutant
Astrid Sydow et al.
JOURNAL OF NEUROSCIENCE (2011)
Amyloid-β/Fyn-Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease
Erik D. Roberson et al.
JOURNAL OF NEUROSCIENCE (2011)
Lest we forget you - methylene blue ...
R. Heiner Schirmer et al.
NEUROBIOLOGY OF AGING (2011)
Tau-Targeted Immunization Impedes Progression of Neurofibrillary Histopathology in Aged P301L Tau Transgenic Mice
Mian Bi et al.
PLOS ONE (2011)
Functional magnetic resonance imaging as a dynamic candidate biomarker for Alzheimer's disease
David Prvulovic et al.
PROGRESS IN NEUROBIOLOGY (2011)
Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia
Michael Ewers et al.
TRENDS IN NEUROSCIENCES (2011)
The acetylation of tau inhibits its function and promotes pathological tau aggregation
Todd J. Cohen et al.
NATURE COMMUNICATIONS (2011)
GSK3 and Alzheimer's disease: facts and fiction
Anna Kremer et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2011)
Meta-Analysis of Alzheimer's Disease Risk with Obesity, Diabetes, and Related Disorders
Louis A. Profenno et al.
BIOLOGICAL PSYCHIATRY (2010)
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Lars M. Ittner et al.
CELL (2010)
Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice
Moran Boimel et al.
EXPERIMENTAL NEUROLOGY (2010)
The Neuroprotective Peptide NAP Does Not Directly Affect Polymerization or Dynamics of Reconstituted Neural Microtubules
Mythili Yenjerla et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
A Caspase Cleaved Form of Tau Is Preferentially Degraded through the Autophagy Pathway
Philip J. Dolan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
APOE4 Allele Disrupts Resting State fMRI Connectivity in the Absence of Amyloid Plaques or Decreased CSF Aβ42
Yvette I. Sheline et al.
JOURNAL OF NEUROSCIENCE (2010)
Epothilone D Improves Microtubule Density, Axonal Integrity, and Cognition in a Transgenic Mouse Model of Tauopathy
Kurt R. Brunden et al.
JOURNAL OF NEUROSCIENCE (2010)
Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model
Allal Boutajangout et al.
JOURNAL OF NEUROSCIENCE (2010)
Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden
John C. O'Leary et al.
MOLECULAR NEURODEGENERATION (2010)
Caspase activation precedes and leads to tangles
Alix de Calignon et al.
NATURE (2010)
Inflammation, microglia, and alzheimer's disease
Brent Cameron et al.
NEUROBIOLOGY OF DISEASE (2010)
Methylene blue fails to inhibit Tau and polyglutamine protein dependent toxicity in zebrafish
Frauke van Bebber et al.
NEUROBIOLOGY OF DISEASE (2010)
Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy
Sang-Won Min et al.
NEURON (2010)
Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration
Brian R. Hoover et al.
NEURON (2010)
Tau protein and tau aggregation inhibitors
Bruno Bulic et al.
NEUROPHARMACOLOGY (2010)
LOSS OF TAU ELICITS AXONAL DEGENERATION IN A MOUSE MODEL OF ALZHEIMER'S DISEASE
H. N. Dawson et al.
NEUROSCIENCE (2010)
A role for FKBP52 in Tau protein function
Beatrice Chambraud et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models
Janet van Eersel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Peripherally Applied Aβ-Containing Inoculates Induce Cerebral β-Amyloidosis
Yvonne S. Eisele et al.
SCIENCE (2010)
Identification of Aminothienopyridazine Inhibitors of Tau Assembly by Quantitative High-Throughput Screening
Alex Crowe et al.
BIOCHEMISTRY (2009)
Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing
Yipeng Wang et al.
HUMAN MOLECULAR GENETICS (2009)
GSK-3: A Key Player in Neurodegeneration and Memory
Karl Peter Giese
IUBMB LIFE (2009)
Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer Disease A Randomized Controlled Trial
Robert C. Green et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Propagation of Tau Misfolding from the Outside to the Inside of a Cell
Bess Frost et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Lithium Trial in Alzheimer's Disease: A Randomized, Single-Blind, Placebo-Controlled, Multicenter 10-Week Study
Harald Hampel et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Human misfolded truncated tau protein promotes activation of microglia and leukocyte infiltration in the transgenic rat model of tauopathy
Norbert Zilka et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Challenges in the conduct of disease-modifying trials in ad: Practical experience from a phase 2 trial of TAU-aggregation inhibitor therapy
C. Wischik et al.
JOURNAL OF NUTRITION HEALTH & AGING (2009)
Transmission and spreading of tauopathy in transgenic mouse brain
Florence Clavaguera et al.
NATURE CELL BIOLOGY (2009)
A novel GSK-3 beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo
L. Sereno et al.
NEUROBIOLOGY OF DISEASE (2009)
Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
Diane P. Hanger et al.
TRENDS IN MOLECULAR MEDICINE (2009)
Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy
Patrice Delobel et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Microglial activation in brain lesions with tau deposits:: Comparison of human tauopathies and tau transgenic mice TgTauP301L
Atsushi Sasaki et al.
BRAIN RESEARCH (2008)
A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics
Hanna Rosenmann et al.
EXPERIMENTAL NEUROLOGY (2008)
A feasibility and tolerability study of lithium in Alzheimer's disease
Alastair Macdonald et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2008)
Changes in folate, vitamin B12 and homocysteine associated with incident dementia
J-M Kim et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Folate Deficiency Induces In Vitro and Mouse Brain Region-Specific Downregulation of Leucine Carboxyl Methyltransferase-1 and Protein Phosphatase 2A Bα Subunit Expression That Correlate with Enhanced Tau Phosphorylation
Jean-Marie Sontag et al.
JOURNAL OF NEUROSCIENCE (2008)
Long-term effects of Aβ42 immunisation in Alzheimer's disease:: follow-up of a randomised, placebo-controlled phase I trial
Clive Holmes et al.
LANCET (2008)
Structure of a protein phosphatase 2A holoenzyme: Insights into B55-mediated Tau dephosphorylation
Yanhui Xu et al.
MOLECULAR CELL (2008)
Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia
Lars M. Ittner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Differential regulation of dynein and kinesin motor proteins by tau
Ram Dixit et al.
SCIENCE (2008)
Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements
Ayodeji A. Asuni et al.
JOURNAL OF NEUROSCIENCE (2007)
High throughput screening for small molecule inhibitors of heparin-induced tau fibril formation
Alex Crowe et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies
Wenjie Luo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model
Erik D. Roberson et al.
SCIENCE (2007)
Protein phosphatase 2A methyltransferase links homocysteine metabolism with tau and amyloid precursor protein regulation
Estelle Sontag et al.
JOURNAL OF NEUROSCIENCE (2007)
Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model
Yasumasa Yoshiyama et al.
NEURON (2007)
Reduction of phosphorylated tau during memantine treatment of Alzheimer's disease
M. Degerman Gunnarsson et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Reduction of soluble Aβ and Tau, but not soluble Aβ alone, ameliorates cognitive decline in transgenic mice with plaques and tangles
Salvatore Oddo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Chronic lithium administration to FTDP-17 tau and GSK-3β overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert
Tobias Engel et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Tau nitration occurs at tyrosine 29 in the fibrillar lesions of Alzheimer's disease and other tauopathies
Matthew R. Reynolds et al.
JOURNAL OF NEUROSCIENCE (2006)
Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein
Hanna Rosenmann et al.
ARCHIVES OF NEUROLOGY (2006)
Cooexpression of FTDP-17 tau and GSK-3β in transgenic mice induce tau polymerization and neurodegeneration
Tobias Engel et al.
NEUROBIOLOGY OF AGING (2006)
Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits
Katharina Schindowski et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Presenilin-1 is an unprimed glycogen synthase kinase-3β substrate
Ciara Twomey et al.
FEBS LETTERS (2006)
Involvement of I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by Memantine
Muhammad Omar Chohan et al.
FEBS LETTERS (2006)
Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species
Chad A. Dickey et al.
JOURNAL OF NEUROSCIENCE (2006)
An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice
Sylvie Le Corre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Antibodies against β-amyloid reduce Aβ oligomers, glycogen synthase kinase-3β activation and τ phosphorylation in vivo and in vitro
QL Ma et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
Rapamycin alleviates toxicity of different aggregate-prone proteins
Z Berger et al.
HUMAN MOLECULAR GENETICS (2006)
In vivo imaging of microglial activation with [C-11](R)-PK11195 PET in progressive supranuclear palsy
A Gerhard et al.
MOVEMENT DISORDERS (2006)
Chronic lithium treatment decreases tau lesions by promoting ubiquitination in a mouse model of tauopathies
H Nakashima et al.
ACTA NEUROPATHOLOGICA (2005)
Fyn kinase induces synaptic and cognitive impairments in a Transgenic mouse model of Alzheimer's disease
J Chin et al.
JOURNAL OF NEUROSCIENCE (2005)
Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation
F Liu et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
In vivo evidence of CHIP up-regulation attenuating tau aggregation
N Sahara et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Tau suppression in a neurodegenerative mouse model improves memory function
K SantaCruz et al.
SCIENCE (2005)
Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms
C Andorfer et al.
JOURNAL OF NEUROSCIENCE (2005)
Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo
W Noble et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease
GB Stokin et al.
SCIENCE (2005)
Accumulation of filamentous tau in the cerebral cortex of human tau R406W transgenic mice
M Ikeda et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model
B Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Alzheimer disease without neocortical neurofibrillary tangles - A second look
P Tiraboschi et al.
NEUROLOGY (2004)
CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation
L Petrucelli et al.
HUMAN MOLECULAR GENETICS (2004)
Accelerated extinction of conditioned taste aversion in P301L tau transgenic mice
L Pennanen et al.
NEUROBIOLOGY OF DISEASE (2004)
The glamour and gloom of glycogen synthase kinase-3
RS Jope et al.
TRENDS IN BIOCHEMICAL SCIENCES (2004)
Aβ immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome
S Oddo et al.
NEURON (2004)
O-GlcNAcylation regulates phosphorylation of tau: A mechanism involved in Alzheimer's disease
F Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Induction of inflammatory mediators and microglial activation in mice transgenic for mutant human P301S tau protein
A Bellucci et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Complete Sequence of a Novel Protein Containing a Femtomolar-Activity-Dependent Neuroprotective Peptide
Merav Bassan et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Intrathecal inflammation precedes development of Alzheimer's disease
E Tarkowski et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
Spherical aggregates of β-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3β
M Hoshi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
GSK-3α regulates production of Alzheimer's disease amyloid-β peptides
CJ Phiel et al.
NATURE (2003)
Microtubule reduction in Alzheimer's disease and aging is independent of τ filament formation
AD Cash et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
GSK-3: tricks of the trade for a multi-tasking kinase
BW Doble et al.
JOURNAL OF CELL SCIENCE (2003)
Chronic lithium treatment decreases mutant tau protein aggregation in a transgenic mouse model
Mar Perez et al.
JOURNAL OF ALZHEIMERS DISEASE (2003)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Role of glycosylation in hyperphosphorylation of tau in Alzheimer's disease
F Liu et al.
FEBS LETTERS (2002)
Homocysteine, folate deprivation and Alzheimer neuropathoelogy
Thomas B. Shea et al.
JOURNAL OF ALZHEIMERS DISEASE (2002)
Hyperphosphorylation induces self-assembly of τ into tangles of paired helical filaments/straight filaments
AD Alonso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration
K Ishizawa et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus
V Vogelsberg-Ragaglia et al.
EXPERIMENTAL NEUROLOGY (2001)
Inhibition of PP-2A upregulates CaMKII in rat forebrain and induces hyperphosphorylation of tau at Ser 262/356
M Bennecib et al.
FEBS LETTERS (2001)
Tau filament formation in transgenic mice expressing P301L tau
J Götz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein
J Lewis et al.
NATURE GENETICS (2000)
Regional distribution of cortical microglia parallels that of neurofibrillary tangles in Alzheimer's disease
LG Sheffield et al.
NEUROSCIENCE LETTERS (2000)
Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain - Implications for neurofibrillary degeneration in Alzheimer's disease
CX Gong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Inflammation and Alzheimer's disease
H Akiyama et al.
NEUROBIOLOGY OF AGING (2000)
分享论文
